Form 4 for LLY Lilly (Eli)
Accepted 2023-12-19 00:00:00 ET · period of report 2023-12-18 · accession 0000059478-23-000326 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-12-19 | 2023-12-18 | LLY | LUCIANO JUAN R | Dir | A - Grant | $579.76 | +25 | 15.6K | +0.2% | +$14.5K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-12-18 | A | A | 25 | $579.76 | 15,569 | D | — | — | (F1) At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service. |